View DividendEnsol Biosciences 관리관리 기준 확인 0/4현재 CEO에 대한 정보가 충분하지 않습니다.주요 정보 최고 경영자n/a총 보상CEO 급여 비율n/aCEO 임기no dataCEO 소유권n/a경영진 평균 재임 기간데이터 없음이사회 평균 재임 기간데이터 없음최근 관리 업데이트Ensol Biosciences Inc., Annual General Meeting, Mar 29, 2021Mar 13모든 업데이트 표시Recent updatesNew minor risk - Shareholder dilution Nov 21Ensol Biosciences Inc. announced that it has received KRW 1.5 billion in funding from Samho Green Investment, Inc.Nov 16New major risk - Share price stability Sep 12Ensol Biosciences Inc. announced that it expects to receive KRW 1 billion in funding from MAGNA Investment Co., Ltd.Sep 11New major risk - Share price stability Jan 27Ensol Biosciences Inc. announced that it has received KRW 2.93 billion in funding from Gluon Bond Investment DayJun 11Ensol Biosciences Inc. announced that it has received KRW 2.93 billion in funding from Gluon Bond Investment DayJun 10Ensol Biosciences Inc. announced that it expects to receive KRW 5 billion in fundingApr 12Ensol Biosciences Inc., Annual General Meeting, Mar 29, 2021Mar 13New 90-day high: ₩22,250 Feb 26Ensol Biosciences Inc. announced that it has received KRW 3 billion in funding from Tiger Asset Management Discretionary Investment Co., Ltd.Feb 17Ensol Biosciences Inc. announced that it expects to receive KRW 3 billion in funding from Tiger Asset Management Discretionary Investment Co., Ltd.Feb 06New 90-day high: ₩19,050 Feb 01New 90-day high: ₩17,300 Jan 05New 90-day low: ₩13,700 Nov 20New 90-day high - ₩17,300 Sep 08New 90-day high - ₩12,450 Jul 17CEOEnsol Biosciences 에는 CEO가 없거나 그에 대한 데이터가 없습니다.View Ownership
Ensol Biosciences Inc. announced that it has received KRW 1.5 billion in funding from Samho Green Investment, Inc.Nov 16
Ensol Biosciences Inc. announced that it expects to receive KRW 1 billion in funding from MAGNA Investment Co., Ltd.Sep 11
Ensol Biosciences Inc. announced that it has received KRW 2.93 billion in funding from Gluon Bond Investment DayJun 11
Ensol Biosciences Inc. announced that it has received KRW 2.93 billion in funding from Gluon Bond Investment DayJun 10
Ensol Biosciences Inc. announced that it has received KRW 3 billion in funding from Tiger Asset Management Discretionary Investment Co., Ltd.Feb 17
Ensol Biosciences Inc. announced that it expects to receive KRW 3 billion in funding from Tiger Asset Management Discretionary Investment Co., Ltd.Feb 06